| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Shinji Makino | Q88425988 |
| P2093 | author name string | Kaori Terasaki | |
| P2860 | cites work | Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action | Q24672548 |
| Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity | Q27305179 | ||
| Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse | Q27305612 | ||
| Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry | Q27478367 | ||
| RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses | Q27487321 | ||
| Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA | Q27491320 | ||
| DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
| Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model, which has important implications for therapeutic development | Q28486013 | ||
| Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model | Q28539632 | ||
| Role of skin immune cells on the host susceptibility to mosquito-borne viruses | Q30837482 | ||
| Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. | Q31149260 | ||
| Multi-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factors | Q33583806 | ||
| Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs | Q33705717 | ||
| Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice | Q34031858 | ||
| Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. | Q34034044 | ||
| Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice. | Q34097995 | ||
| The pathogenesis of Rift Valley fever | Q34191969 | ||
| Innate immune response to Rift Valley fever virus in goats | Q34251382 | ||
| The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts | Q34440401 | ||
| Rift Valley fever virus | Q34971963 | ||
| NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. | Q35024013 | ||
| The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3. | Q35076535 | ||
| Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes | Q35097798 | ||
| Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation | Q35704771 | ||
| Development of a novel nonhuman primate model for Rift Valley fever | Q35826546 | ||
| Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus. | Q36159670 | ||
| NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
| Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. | Q36501737 | ||
| The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function | Q36506825 | ||
| RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge | Q36759999 | ||
| Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses | Q36827204 | ||
| IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus | Q37036679 | ||
| IL-10: the master regulator of immunity to infection | Q37143028 | ||
| Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets | Q37547173 | ||
| Virus isolations and high population density implicate Culex antennatus (Becker) (Diptera: Culicidae) as a vector of Rift Valley Fever virus during an outbreak in the Nile Delta of Egypt | Q39044207 | ||
| NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
| Chemotaxis of T-cells after infection of human choroid plexus papilloma cells with Echovirus 30 in an in vitro model of the blood-cerebrospinal fluid barrier | Q39274013 | ||
| The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
| Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
| Heparan sulfate facilitates Rift Valley fever virus entry into the cell | Q40273179 | ||
| Ultrastructural study of Rift Valley fever virus in the mouse model | Q40283964 | ||
| Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. | Q40308414 | ||
| Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene | Q40311587 | ||
| DC-SIGN as a receptor for phleboviruses | Q40318139 | ||
| The pathogenesis of Rift Valley fever virus in the mouse model | Q40348320 | ||
| Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Rift Valley fever virus-induced encephalomyelitis and hepatitis in calves | Q40727210 | ||
| Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine | Q40759549 | ||
| Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response | Q40768376 | ||
| Viral determinants of virulence for Rift Valley fever (RVF) in rats | Q40782624 | ||
| Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity | Q42153057 | ||
| P433 | issue | 5 | |
| P921 | main subject | Rift Valley fever | Q326638 |
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 450-458 | |
| P577 | publication date | 2015-02-27 | |
| P1433 | published in | Journal of Innate Immunity | Q15817533 |
| P1476 | title | Interplay between the Virus and Host in Rift Valley Fever Pathogenesis | |
| P478 | volume | 7 |
| Q28554535 | Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence |
| Q36208133 | Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin |
| Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
| Q92543295 | Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle |
| Q63246310 | The influence of raw milk exposures on Rift Valley fever virus transmission |
| Q53775485 | Visions and the Progress of Science. |
Search more.